By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences ...

How to Inject Semaglutide This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ...

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

Semaglutide Market Size To Reach USD 59.75 Billion By 2033, Experiencing High Demand For An Efficient Treatment For Diabetes ...

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

Semaglutide 2.4 mg improves insulin sensitivity and glycemic outcomes in adolescents with obesity, according to a secondary analysis of STEP TEENS.

Lupin has inked a licensing and supply agreement with Galenicum Health for finished formulations of injectable Semaglutide, ...

Noveltreat to be available in five dose strengths of 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL and 2.4 ...

Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals and commercialization and distribution.

A large meta-analysis, published in Diabetology & Metabolic Syndrome, suggested that semaglutide improved several liver-related and metabolic outcomes in people with or at risk of developing MASH, ...

The AACE has updated its guidance on obesity and adiposity-based chronic disease to reflect a focus on improving overall ...